These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31846689)

  • 21. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
    Wang T; Abou-Ouf H; Hegazy SA; Alshalalfa M; Stoletov K; Lewis J; Donnelly B; Bismar TA
    J Mol Med (Berl); 2016 Dec; 94(12):1411-1422. PubMed ID: 27534968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma.
    Lombardi G; Corona G; Bellu L; Della Puppa A; Pambuku A; Fiduccia P; Bertorelle R; Gardiman MP; D'Avella D; Toffoli G; Zagonel V
    Oncologist; 2015 May; 20(5):562-7. PubMed ID: 25862748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
    Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
    Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer.
    Gonthier K; Poluri RTK; Weidmann C; Tadros M; Audet-Walsh É
    Mol Cancer Res; 2019 Aug; 17(8):1699-1709. PubMed ID: 31068457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).
    Bonaccorsi L; Carloni V; Muratori M; Formigli L; Zecchi S; Forti G; Baldi E
    Int J Cancer; 2004 Oct; 112(1):78-86. PubMed ID: 15305378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling.
    Tian H; Chou FJ; Tian J; Zhang Y; You B; Huang CP; Yeh S; Niu Y; Chang C
    J Exp Clin Cancer Res; 2021 Jan; 40(1):3. PubMed ID: 33390173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor is a tumor suppressor and proliferator in prostate cancer.
    Niu Y; Altuwaijri S; Lai KP; Wu CT; Ricke WA; Messing EM; Yao J; Yeh S; Chang C
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12182-7. PubMed ID: 18723679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
    Li L; Paz AC; Wilky BA; Johnson B; Galoian K; Rosenberg A; Hu G; Tinoco G; Bodamer O; Trent JC
    PLoS One; 2015; 10(9):e0133813. PubMed ID: 26368816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.
    Luo J; Lee SO; Cui Y; Yang R; Li L; Chang C
    Oncotarget; 2015 Sep; 6(29):27555-65. PubMed ID: 26342197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.
    Gerdes MJ; Dang TD; Larsen M; Rowley DR
    Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cells promote metastasis of prostate cancer by enhancing autophagy.
    Zhao R; Bei X; Yang B; Wang X; Jiang C; Shi F; Wang X; Zhu Y; Jing Y; Han B; Xia S; Jiang Q
    J Exp Clin Cancer Res; 2018 Sep; 37(1):221. PubMed ID: 30200999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor and invasion in prostate cancer.
    Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE
    Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
    Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
    Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells.
    Yu L; Wang CY; Shi J; Miao L; Du X; Mayer D; Zhang J
    Endocrinology; 2011 Mar; 152(3):773-81. PubMed ID: 21248144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.
    Gang X; Wang G; Huang H
    Prostate; 2015 May; 75(6):561-72. PubMed ID: 25631036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
    Diallo JS; Péant B; Lessard L; Delvoye N; Le Page C; Mes-Masson AM; Saad F
    Prostate; 2006 Sep; 66(12):1245-56. PubMed ID: 16705740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism.
    Rendina AR; Pietrak B; Smallwood A; Zhao H; Qi H; Quinn C; Adams ND; Concha N; Duraiswami C; Thrall SH; Sweitzer S; Schwartz B
    Biochemistry; 2013 Jul; 52(26):4563-77. PubMed ID: 23731180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.
    Caggia S; Chunduri H; Millena AC; Perkins JN; Venugopal SV; Vo BT; Li C; Tu Y; Khan SA
    J Cell Physiol; 2018 Jan; 234(1):802-815. PubMed ID: 30078221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.